Review: the multicolored coordination chemistry of violurate anions

Synthesis and characterization of violurate - based Mn(II) and Cu(II) complexes nano-crystallites as DNA-binders and therapeutics agents against SARS-CoV-2 virus

Synthesis and structural characterization of nano crystallites of bis-violurate-based manganese(II) and copper(II) chelates is the subject of the present study. Analytical data and mass spectra as well as thermal analysis determined the molecular formulas of the present metal chelates. Spectroscopic and magnetic measurements assigned the structural formula of the present violurate metal complexes. The spectroscopic and magnetic investigations along with structural analysis results indicated the square planar geometry of both the Mn(II) and Cu(II) complexes. The structural analysis of the synthesized metal complexes was achieved by processing the PXRD data using specialized software Expo 2014. Spectrophotometeric and viscosity measurements showed that violuric acid and its Mn(II) and Cu(II) complexes successfully bind to DNA with intrinsic binding constants K_b from 38.2 × 10⁵ to 26.4 × 10⁶ M⁻¹. The antiviral activity study displayed that the inhibitory concentrations (IC₅₀) of SARS-CoV-2 by violuric acid and its Mn(II) and Cu(II) complexes are 84.01, 39.58 and 44.86 μM respectively. Molecular docking calculations were performed on the SARS-CoV-2 virus protein and the computed binding energy values are −0.8, −3.860 −5.187 and −4.790, kcal/mol for the native ligand, violuric acid and its Mn(II) and Cu(II) complexes respectively. Insights into the relationship between structures of the current compounds and their degree of reactivity are discussed.

Carbodiimide-Mediated Beckmann Rearrangement of Oxyma-B as a Side Reaction in Peptide Synthesis

The suppression of side reactions is one of the most important objectives in peptide synthesis, where highly reactive compounds are involved. Recently, the violuric acid derivative Oxyma-B was introduced into peptide synthesis protocols as a promising additive to efficiently control the optical purity of the amino acids prone to racemization. However, we discovered a side reaction involving the Beckmann rearrangement of Oxyma-B during the coupling reaction, which compromises the yield and purity of the target peptides. Here, we present the investigation of the mechanism of this rearrangement and the optimization of the coupling reaction conditions to control it. These results can be taken into account for the design of novel efficient oxime-based coupling reagents.

Small compound - big colors: synthesis and structural investigation of brightly colored alkaline earth metal 1,3-dimethylviolurates

A series of brightly colored alkaline earth metal 1,3-dimethylviolurates M(Me₂Vio)₂ have been prepared and fully characterized. The title compounds AE(Me₂Vio)₂·nH₂O (AE = Mg, n = 6 (3); AE = Ca, n = 8 (4), AE = Sr, n = 6 (5); AE = Ba, n = 4 (6)) were obtained by neutralizing 1,3-dimethylvioluric acid monohydrate (=H(Me₂Vio)·H₂O; 2) with 0.5 equiv. of the corresponding metal dihydroxides AE(OH)₂. The hair-like appearance of the Sr derivative 5 prevented the growth of single-crystals. This problem could be solved by crystallizing the crown ether derivative Sr(Me₂Vio)₂(18-crown-6) (5a). The isolated salts exhibit intense colors ranging from red to purple. Various attempts to prepare the beryllium derivative Be(Me₂Vio)₂ failed. Instead, work-up of the reaction mixtures provided pink crystals of a new modification of 2 formulated as [H₃O][Me₂Vio] (2b) as shown by an X-ray diffraction study. An unexpected oxidation reaction of the barium salt Ba(Me₂Vio)₂ led to formation of the novel mixed-anion salt Ba(Me₂Vio)(Me₂NO₂Barb)·2H₂O (8, Me₂NO₂Barb^- = 1,3-dimethyl-5-nitrobarbiturate anion). Compound 8 could also be synthesized deliberately by treatment of Ba(OH)₂ with a 1 : 1 mixture of 2 and 1,3-dimethyl-5-nitrobarbituric acid (7, =H(Me₂NO₂Barb)·H₂O). All new compounds were fully characterized by their IR, Raman, NMR (¹H, ¹³C{¹H}) and UV-vis spectra as well as elemental analyses. Single-crystal X-ray diffraction studies revealed that the solid-state structures of compounds 3, 4, 5a and 6 are governed by the typical coordination behavior of the alkaline-earth metals, i.e. increasing coordination numbers and a decreasing degree of hydration when going from Mg to Ba. The dimensions of the structures range from hydrogen-bonded ions (3) over monomeric, neutral complex molecules (4, 5a), to polymeric networks (6). The successful isolation of the mixed-anion barium salt 8 adds a new facet to the coordination chemistry of violurate and related ligands.

Construction of targeted drug-loaded composite polysaccharide hydrogels and verification of anti-tumor effect in vitro

A targeted composite polysaccharide drug-loaded gel was obtained and characterized. It displayed potent anti-tumor activity via specific binding between the folate in the gel and the folate receptors in the cell membrane.

Crystal structure of a binuclear mixed-valence ytterbium complex containing a 2-anthracene-substituted phenoxide ligand

The crystal structure of a binuclear mixed-valence ytterbium complex containing bridging and terminal 2-anthracene-substituted phenoxide ligands is described. One of the bridging ligands shows a π-inter­action between an anthracene bond and the ytterbium(II) centre.

Reaction of 2-(anthracen-9-yl)phenol (HOPhAn, 1) with divalent Yb[N(SiMe₃)₂]₂·2THF in THF–toluene mixtures affords the mixed-valence Yb^II–Yb^III dimer {[2-(anthracen-9-yl)phenolato-κO]bis­(tetra­hydro­furan)­ytterbium(III)}-tris­[μ-2-(anthracen-9-yl)phenolato]-κ⁴O:O;κO:1,2-η,κO-{[2-(anthracen-9-yl)phenolato-κO]ytterbium(II)} toluene tris­olvate, [Yb₂(C₂₀H₁₃O)₅(C₄H₈O)₂]·3C₇H₇ or [Yb^III(THF)₂(OPhAn)](μ-OPhAn)₃[Yb^II(OPhAn)]·3C₇H₇ (2), as the major product. It crystallized as a toluene tris­olvate. The Yb—O bond lengths in the crystal structure of this dimer clearly identify the Yb^II and Yb^III centres. Inter­estingly, the formally four-coordinate Yb^II centre shows a close contact with one anthracene C—C bond of a bridging OPhAn ligand, bringing the formal coordination number to five.